EpiCard E-Team featured in NY Times

The EpiCard E-Team, makers of a smaller, more manageable epinephrine injector for people with severe allergies, is officially on the market as Auvi-Q. Read this NY Times story to follow Evan and Eric Edwards as they moved from a small E-Team grant of $13,769 in 2000 to eventually licensing the product to Sanofi for $230m in 2009.